Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis - PubMed
Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis
Axel Nierhaus et al. Intensive Care Med. 2003 Apr.
Abstract
Objective: To evaluate the effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on immunoparalysis as defined by a sustained decrease of HLA-DR expression on monocytes in patients with severe sepsis.
Design: Prospective, non-randomised observational study.
Setting: Two anaesthesiological intensive care units of a university hospital.
Intervention: Administration of a daily dose of 5 micro g/kg rhGM-CSF over a period of 3 days.
Patients: Nine consecutive patients with severe sepsis and a documented HLA-DR expression on peripheral monocytes of less than 150 mean fluorescence intensity (MFI) over a period of at least 48 h prior to intervention.
Measurements and results: Mean MFI was 69.4+/-13.2 24 h before and 56.7+/-8.2 on the day of the administration of 5 micro g/kg rhGM-CSF. Within 24 h a significant increase of HLA-DR expression to a mean of 327.7+/-78.8 MFI was observed in all patients. This increase was maintained on days 2-10. It was accompanied by a significant rise in white blood count. The ex vivo TNF-alpha production in whole blood after lipopolysaccharide (LPS)-stimulation increased significantly from a mean of 82+/-29.2 pg/ml to 793+/-546.8 pg/ml. Apart from febrile reactions in two patients, no side effects were recorded. No increases of pro-inflammatory markers (IL-6, C-reactive protein, LPS-binding protein, procalcitonin) were observed. SOFA values before and after rhGM-CSF did not differ significantly. The mortality rate was 33%.
Conclusion: This preliminary study demonstrates that rhGM-CSF upregulates HLA-DR expression on monocytes in septic patients with multi-organ dysfunction. Moreover, with the concomitant increase of the ex vivo whole blood TNF-alpha response, this upregulation of a monocytic activation marker is paralleled by a functional recovery.
Similar articles
-
In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
Drossou-Agakidou V, Kanakoudi-Tsakalidou F, Sarafidis K, Tzimouli V, Taparkou A, Kremenopoulos G, Germenis A. Drossou-Agakidou V, et al. Cytokine. 2002 Jun 7;18(5):260-5. doi: 10.1006/cyto.2002.1037. Cytokine. 2002. PMID: 12161101 Clinical Trial.
-
Flohé S, Lendemans S, Selbach C, Waydhas C, Ackermann M, Schade FU, Kreuzfelder E. Flohé S, et al. Crit Care Med. 2003 Oct;31(10):2462-9. doi: 10.1097/01.CCM.0000089640.17523.57. Crit Care Med. 2003. PMID: 14530752
-
Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.
Joshi I, Carney WP, Rock EP. Joshi I, et al. Front Immunol. 2023 Feb 7;14:1130214. doi: 10.3389/fimmu.2023.1130214. eCollection 2023. Front Immunol. 2023. PMID: 36825018 Free PMC article. Review.
-
The effects of rhGM-CSF on macrophage function.
Jones TC. Jones TC. Eur J Cancer. 1993;29A Suppl 3:S10-3. doi: 10.1016/0959-8049(93)90625-p. Eur J Cancer. 1993. PMID: 8398363 Review.
Cited by
-
Innate immune function and mortality in critically ill children with influenza: a multicenter study.
Hall MW, Geyer SM, Guo CY, Panoskaltsis-Mortari A, Jouvet P, Ferdinands J, Shay DK, Nateri J, Greathouse K, Sullivan R, Tran T, Keisling S, Randolph AG; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network PICFlu Study Investigators. Hall MW, et al. Crit Care Med. 2013 Jan;41(1):224-36. doi: 10.1097/CCM.0b013e318267633c. Crit Care Med. 2013. PMID: 23222256 Free PMC article.
-
Re-Evaluating Biologic Pharmacotherapies that Target the Host Response during Sepsis.
Tuttle K, McDonald M, Anderson E. Tuttle K, et al. Int J Mol Sci. 2019 Nov 30;20(23):6049. doi: 10.3390/ijms20236049. Int J Mol Sci. 2019. PMID: 31801287 Free PMC article. Review.
-
How Clinical Flow Cytometry Rebooted Sepsis Immunology.
Monneret G, Gossez M, Aghaeepour N, Gaudilliere B, Venet F. Monneret G, et al. Cytometry A. 2019 Apr;95(4):431-441. doi: 10.1002/cyto.a.23749. Epub 2019 Mar 19. Cytometry A. 2019. PMID: 30887636 Free PMC article. Review.
-
Flohé SB, Agrawal H, Flohé S, Rani M, Bangen JM, Schade FU. Flohé SB, et al. Mol Med. 2008 May-Jun;14(5-6):247-56. doi: 10.2119/2007-00120.Flohe. Mol Med. 2008. PMID: 18297128 Free PMC article.
-
Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis.
Poutsiaka DD, Davidson LE, Kahn KL, Bates DW, Snydman DR, Hibberd PL. Poutsiaka DD, et al. Scand J Infect Dis. 2009;41(6-7):469-79. doi: 10.1080/00365540902962756. Scand J Infect Dis. 2009. PMID: 19452348 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials